Functional assessment of a promoter polymorphism in S100B, a putative risk variant for bipolar disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 6, 2011, Pages 691-699

  Dagdan, Elif ^a   Morris, Derek W ^a   Campbell, Matthew ^a   Hill, Matthew ^a   Rothermundt, Matthias ^b   Kästner, Florian ^b   Hohoff, Christa ^b   von Eiff, Christof ^b   Krakowitzky, Petra ^b   Gill, Michael ^a   Mckeon, Patrick ^a,c   Roche, Siobhan ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c St Patrick's University Hospital   (Ireland)

Author keywords

Bipolar disorder; Gene expression; Promoter; S100B; Serum

Indexed keywords

LUCIFERASE; PROTEIN S100B;

ALLELE; ARTICLE; BIPOLAR DISORDER; CELL LINE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

BASE SEQUENCE; BIPOLAR DISORDER; CALCIUM-BINDING PROTEINS; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, REPORTER; GERMANY; GLIOBLASTOMA; HUMANS; IRELAND; LUCIFERASES; NERVE GROWTH FACTORS; NEUROBLASTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; S100 PROTEINS; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA;

EID: 80051575444     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31211     Document Type: Article

References (46)

1. Allore R, O'Hanlon D, Price R, Neilson K, Willard HF, Cox DR, Marks A, Dunn RJ. 1988. Gene encoding the beta subunit of S100 protein is on chromosome 21: Implications for Down syndrome. Science 239: 1311-1313.
2. Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Ceresér KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Gonçalves CA. 2007. S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41(6): 523-529.
3. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, Kirchner H, Rothermundt M. 2003. S100B and response to treatment in major depression: A pilot study. Eur Neuropsychopharmacol 13: 235-239.
4. Badner JA, Gershon ES. 2002. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7: 405-411.
5. Baron M. 2002. Manic-depression genes and the new millennium: Poised for discovery. Mol Psychiatry 7: 342-358.
6. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. 1991. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48: 996-1001.
7. Brauch RA, Adnan El-Masri M, Parker JC Jr, El-Mallakh RS. 2006. Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals. J Affect Disord 91: 87-90.
8. Cassidy F, Zhao C, Badger J, Claffey E, Dobrin S, Roche S, McKeon P. 2007. A bipolar disorder whole genome linkage scan and an investigation of population stratification effects: Support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24 and 16p13. Am J Med Genet B Neuropsychiatr Genet 5 144B(6): 791-801.
9. Castets F, Griffin WS, Marks A, Van Eldik LJ. 1997. Transcriptional regulation of the human S100 beta gene. Brain Res Mol Brain Res 46: 208-216.
10. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. 2001. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58: 545-553.
11. Demirhan O, Tatemir D. 2003. Chromosome aberrations in a schizophrenia population. Schizophr Res 65: 1-7.
12. Donato R. 2007. RAGE. A single receptor for several ligands and different cellular responses. The case of certain S100 proteins. Curr Mol Med 7: 711-724.
13. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I. 2009. S100B's double life: Intracellular regulator and extracellular signal. Biochim Biophys Acta 1793(6): 1008-1022.
14. Himeda CL, Ranish JA, Angello JC, Maire P, Aebersold R, Hauschka SD. 2004. Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer. Mol Cell Biol 24: 2132-2143.
15. Hohoff C, Ponath G, Freitag CM, Kästner F, Krakowitzky P, Domschke K, Koelkebeck K, Kipp F, von Eiff C, Deckert J, Rothermundt M. 2010. Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals. Am J Med Genet Part B Neuropsychiatr Genet 153B(1): 291-297.
16. Kawakami K, Sato S, Ozaki H, Ikeda K. 2000. Six family genes structure and function as transcription factors and their roles in development. Bioessays 22: 616-626.
17. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, Spurlock G, Norton N, Williams H, Williams N, Lovestone S, Perez-Tur J, Hutton M, Chartier-Harlin MC, Shears S, Roehl K, Booth J, Van Voorst W, Ramic D, Williams J, Goate A, Hardy J, Owen MJ. 1999. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8: 237-245.
18. Ling SH, Tang YL, Jiang F, Wiste A, Guo SS, Weng YZ, Yang TS. 2007. Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment. J Psychiatr Res 41: 36-42.
19. Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, Loth JE, Kanyas K, Lerer B, Endicott J, Penchaszadeh G, Gilliam TC, Baron M. 2001. A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22. Am J Med Genet 8 105(2): 189-194.
20. Liu J, Shi Y, Tang J, Guo T, Li X, Yang Y, Chen Q, Zhao X, He G, Feng G, Gu N, Zhu S, Liu H, He L. 2005. SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem Biophys Res Commun 328: 335-341.
21. Machado-Vieira R, Lara DR, Portela LV, Gonçalves CA, Soares JC, Kapczinski F, Souza DO. 2002. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: A pilot study. Eur Neuropsychopharmacol 12: 269-272.
22. Machado-Vieira R, Schmidt AP, Avila TT, Kapczinski F, Soares JC, Souza DO, Portela LV. 2004. Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain. Life Sci 76: 805-811.
23. McQuillin A, Bass NJ, Kalsi G, Lawrence J, Puri V, Choudhury K, Detera-Wadleigh SD, Curtis D, Gurling HM. 2006. Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3. Mol Psychiatry 11(2): 134-142.
24. Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L, Kaleem M, Leung D, Bryden L, Nath P, Zismann VL, Joshipura K, Huentelman MJ, Hu-Lince D, Coon KD, Craig DW, Pearson JV, Holmans P, Heward CB, Reiman EM, Stephan D, Hardy J. 2007. A survey of genetic human cortical gene expression. Nat Genet 39: 1494-1499.
25. Ohto H, Takizawa T, Saito T, Kobayashi M, Ikeda K, Kawakami K. 1998. Tissue and developmental distribution of Six family gene products. Int J Dev Biol 42: 141-148.
26. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. 2004. ECR Browser: A tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32: W280-W286.
27. Peskind ER, Griffin WS, Akama KT, Raskind MA, Van Eldik LJ. 2001. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem Int 39: 409-413.
28. Reiber H. 2001. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310: 173-186.
29. Roche S, Cassidy F, Zhao C, Badger J, Claffey E, Mooney L, Delaney C, Dobrin S, McKeon P. 2007. Candidate gene analysis of 21q22: Support for S100B as a susceptibility gene for bipolar affective disorder with psychosis. Am J Med Genet Part B 144B: 1094-1096.
30. Rothermundt M, Missler U, Arolt V, Peters M, Leadbeater J, Wiesmann M, Rudolf S, Wandinger KP, Kirchner H. 2001. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry 6: 445-449.
31. Rothermundt M, Peters M, Prehn JH, Arolt V. 2003. S100B in brain damage and neurodegeneration. Microsc Res Tech 60: 614-632.
32. Rothermundt M, Ponath G, Arolt V. 2004a. S100B in schizophrenic psychosis. Int Rev Neurobiol 59: 445-470.
33. Rothermundt M, Falkai P, Ponath G, Abel S, Bürkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V. 2004b. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 9: 897-899.
34. Rothermundt M, Ponath G, Glaser T, Hetzel G, Arolt V. 2004c. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology 29: 1004-1011.
35. Rothermundt M, Ohrmann P, Abel S, Siegmund A, Pedersen A, Ponath G, Suslow T, Peters M, Kaestner F, Heindel W, Arolt V, Pfleiderer B. 2007. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol. Prog Neuropsychopharmacol Biol Psychiatry 31: 361-436.
36. Schroeter ML, Abdul-Khaliq H, Diefenbacher A, Blasig IE. 2002. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport 13: 1675-1678.
37. Schroeter ML, Abdul-Khaliq H, Frühauf S, Höhne R, Schick G, Diefenbacher A, Blasig IE. 2003. Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia. Schizophr Res 62: 231-236.
38. Sen J, Belli A. 2007. S100B in neuropathologic states: The CRP of the brain? J Neurosci Res 85: 1373-1380.
39. Steiner J, Bielau H, Bernstein HG, Bogerts B, Wunderlich MT. 2006. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry 77: 1284-1287.
40. Steiner J, Myint AM, Schiltz K, Westphal S, Bernstein HG, Walter M, Schroeter ML, Schwarz MJ, Bogerts B. 2010. S100B serum levels in Schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovasc Psychiatry Neurol 2010: 480707. PubMed ID 20631894.
41. Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L, Alexander JR, Das K, Simon R, Fieve RR, Lerer B, Endicott J, Ott J, Gilliam TC, Baron M. 1994. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet 8: 291-296.
42. Tsoporis JN, Marks A, Van Eldik LJ, O'Hanlon D, Parker TG. 2003. Regulation of the S100B gene by alpha 1-adrenergic stimulation in cardiac myocytes. Am J Physiol Heart Circ Physiol 284: H193-203.
43. Webster MJ, O'Grady J, Kleinman JE, Weickert CS. 2005. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 133: 453-461.
44. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 7 447(7145): 661-678.
45. Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, Kirchner H. 1999. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry 45: 1508-1511.
46. Yang K, Xie GR, Hu YQ, Mao FQ, Su LY. 2009. Association study of astrocyte-derived protein S100B gene polymorphisms with major depressive disorder in Chinese people. Can J Psychiatry 54(5): 312-319.